跳至主要内容
临床试验/NCT03837769
NCT03837769已完成不适用

Single-center Intervention Study to Validate the Performance of the Aktiia SA PulseWatch Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Invasive Blood Pressure Measurements With Arterial Line

Hopital Neuchatelois2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2019年2月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
31
试验地点
2
主要终点
Cuffless Blood Pressure performance

研究概览

简要总结

Single-centre intervention study to validate the performance of the Aktiia SA optical blood pressure monitoring (OBPM) device at the wrist against invasive blood pressure measurements with arterial line.

详细描述

Aktiia SA PulseWatch is an investigational device for the optical measurement of blood pressure that uses only optical sensors at the wrist. HNE is interested in exploring the potential of the device and technology (OBPM), and aims at benchmarking its performances against gold standard measurements of blood pressure.

The goal of this study is thus to assess whether i) PulseWatch allows to capture blood pressure variations, and ii) the measured blood pressure values remain stable in time.

The proposed study plans to include patients that are already scheduled for arterial catheterization at HNE. For these patients, the study will only require the placement of the safe optical device on the wrist to non-invasively record hemodynamic fluctuations. Therefore, no additional risk for the patient is to be foreseen.

By demonstrating that the Aktiia SA OBPM technology is reliable, HNE aims to make one step further in improving blood pressure monitoring in general, and in particular in advancing the deployment of technologies that have the potential to be used in the ambulatory setting. The diagnosis and treatment of hypertension are expected to largely benefit from these advancements.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • No significant non-invasive systolic blood pressure difference between left arm and right arm (difference <20mmHg in systolic arterial pressure)
  • Patient requires continuous monitoring of diastolic and systolic blood pressure continuously via a radial arterial line;
  • Patient information and informed consent is obtained following the procedures described in CIP

排除标准

  • Arrythmias: tachycardia (resting heart rate > 120/min) at time of study inclusion
  • Atrial fibrillation
  • Psychomotor agitation
  • Significant bruises or trauma on forearm
  • Intravenous canula around the wrist with impossibility to place the device (Aktiia OBPM PulseWatch) around the wrist

结局指标

主要结局

Cuffless Blood Pressure performance

时间窗: 4 Months

The evaluation of the accuracy (mean error and standard deviation of the error) of the non-invasive BP measurements at wrist with the PulseWatch against the reference gold-standard invasive blood pressure obtained by arterial line with respect to ISO 81060-2 (14) for two aspects: i) capturing the variations of the BP in short time and ii) maintaining the accurate stable measurements over extended periods of time.

次要结局

未报告次要终点

研究者

发起方
Hopital Neuchatelois
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验